BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14598733)

  • 1. [The role of the components of the renin-angiotensin system in the ocular tissues in norm and pathology].
    Chesnokova NB; Grigor'ev AV; Pavlenko TA; Nikol'skaia II; Kost OA; Kazanskaia NF
    Vestn Ross Akad Med Nauk; 2003; (9):29-32. PubMed ID: 14598733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ocular renin-angiotensin system: a therapeutic target for the treatment of ocular disease.
    Giese MJ; Speth RC
    Pharmacol Ther; 2014 Apr; 142(1):11-32. PubMed ID: 24287313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin levels in the eye.
    Danser AH; Derkx FH; Admiraal PJ; Deinum J; de Jong PT; Schalekamp MA
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1008-18. PubMed ID: 8125711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renin-angiotensin system in the rabbit eye.
    Ramirez M; Davidson EA; Luttenauer L; Elena PP; Cumin F; Mathis GA; De Gasparo M
    J Ocul Pharmacol Ther; 1996; 12(3):299-312. PubMed ID: 8875336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes and retinal vascular disorders: role of the renin-angiotensin system.
    Wilkinson-Berka JL
    Expert Rev Mol Med; 2004 Jul; 6(15):1-18. PubMed ID: 15387897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four decades of ocular renin-angiotensin and kallikrein-kinin systems (1977-2017).
    Igić R
    Exp Eye Res; 2018 Jan; 166():74-83. PubMed ID: 28549900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renin-angiotensin system and diabetic retinopathy.
    Kohner EM
    Klin Wochenschr; 1992; 69 Suppl 29():25-7. PubMed ID: 1614187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
    Bilous R
    Prim Care Diabetes; 2008 Dec; 2(4):201-2. PubMed ID: 18760685
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydration, fluid regulation and the eye: in health and disease.
    Sherwin JC; Kokavec J; Thornton SN
    Clin Exp Ophthalmol; 2015 Nov; 43(8):749-64. PubMed ID: 25950246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Choline in Ocular Diseases.
    Hwang JS; Shin YJ
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lifestyle-related diseases and anti-aging ophthalmology: suppression of retinal and choroidal pathologies by inhibiting renin-angiotensin system and inflammation].
    Ishida S
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):403-22; discussion 423. PubMed ID: 19348185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue renin-angiotensin systems. Their role in cardiovascular disease.
    Lee MA; Böhm M; Paul M; Ganten D
    Circulation; 1993 May; 87(5 Suppl):IV7-13. PubMed ID: 8485836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue Renin-Angiotensin System in Lacrimal Gland Fibrosis in a Murine Model of Chronic Graft-Versus-Host Disease.
    Yaguchi S; Ogawa Y; Kawakita T; Shimmura S; Tsubota K
    Cornea; 2015 Nov; 34 Suppl 11():S142-52. PubMed ID: 26448172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [(Pro) renin receptor in the pathogenesis of proliferative diabetic retinopathy].
    Kanda A
    Nippon Ganka Gakkai Zasshi; 2014 Nov; 118(11):916-26. PubMed ID: 25543383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence and physiologic function of the renin-angiotensin system in mouse lacrimal gland.
    Yaguchi S; Ogawa Y; Shimmura S; Hatou S; Nakamura S; Inaba T; Imada T; Ozawa Y; Kawakami Y; Ishida S; Tsubota K
    Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5416-25. PubMed ID: 22786901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An ocular renin-angiotensin system. Immunohistochemistry of angiotensinogen.
    Sramek SJ; Wallow IH; Tewksbury DA; Brandt CR; Poulsen GL
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1627-32. PubMed ID: 1559760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.
    Steckelings UM; Rompe F; Kaschina E; Unger T
    Fundam Clin Pharmacol; 2009 Dec; 23(6):693-703. PubMed ID: 19817870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative pathways in the development of diabetic retinopathy: the renin-angiotensin and kallikrein-kinin systems.
    Phipps JA; Jobling AI; Greferath U; Fletcher EL; Vessey KA
    Clin Exp Optom; 2012 May; 95(3):282-9. PubMed ID: 22594546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy.
    Sjølie AK; Chaturvedi N
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S42-6. PubMed ID: 12140727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy.
    Danser AH; van den Dorpel MA; Deinum J; Derkx FH; Franken AA; Peperkamp E; de Jong PT; Schalekamp MA
    J Clin Endocrinol Metab; 1989 Jan; 68(1):160-7. PubMed ID: 2642484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.